The Korean Society of Pediatric Hematology Oncology   Report issue

Academic/Hospital Phase 2
Founded: Seoul Korea, Republic of (1993)

Organization Overview

First Clinical Trial
2006
NCT00737685
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

The Korean Society of Pediatric Hematology Oncology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 2)

Anemia, Aplastic (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Syndrome (Phase 2)

Wiskott-Aldrich Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 6